EFFICIENCY OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1763

Full metadata record

DC Field	Value	Language
dc.contributor.author	Пулатова Шахноза Бахтияровна	-
dc.date.accessioned	2022-01-25T05:52:12Z	-
dc.date.available	2022-01-25T05:52:12Z	-
dc.date.issued	2022-01	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1763	-
dc.description.abstract	A review of recommendations for the use of tumor necrosis factor α (TNF-α) inhibitors in patients with ankylosing spondylitis (AS) is presented. The data on the efficacy of TNF-α in patients with AS are presented. On the basis of international and domestic recommendations, indications for the appointment of this therapy, criteria for assessing its effectiveness and safety are formulated.	en_US
dc.language.iso	en	en_US
dc.publisher	London. United Kingdom	en_US
dc.relation.ispartofseries	Volume-2, No 1;	-
dc.subject	ankylosing spondylitis; tumor necrosis factor-α inhibitors; efficiency; safety.	en_US
dc.title	EFFICIENCY OF INHIBITORS OF TUMOR NECROSIS FACTOR-Α IN THE TREATMENT OF ANKYLOSING SPONDILOARTHRITIS	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Angliya OAK British medical journal.pdf		556.34 kB	Adobe PDF	View/Open

DSpace JSPUI